Project Details
Description
The project aims to strengthen the research at Rīga Stradiņš University (RSU, Latvia) in the area of smart specialisation, namely, “bio-medicine, medical technologies, and biotechnologies” in the direction of cancer immunotherapy by establishing a closer cooperation with two internationally leading research institutions – the Institute of Microbiology, Tumour and Cell Biology, Karolinska Institutet (Sweden), the Department of General Biophysics, University of Lodz (Poland) and the R. E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology of National Academy of Sciences of Ukraine.
| Acronym | VACTRAIN |
|---|---|
| Status | Finished |
| Effective start/end date | 1/01/16 → 31/12/18 |
| Links | https://www.rsu.lv/en/project/twinning-dna-based-cancer-vaccines-vactrain http://www.vactrain.lv/ |
Collaborative partners
- Rīga Stradiņš University (lead)
- Karolinska Institutet (Project partner)
- Uniwersytet Lodziki (Project partner)
- R.E. Kavetsky Institute of Experimental Pathology, Oncology, and Radiobiology, KIEPOR (Project partner)
Total Funding
- European Commission: €999,475.00
Keywords
- Cluster dynamics
- immunotherapy of cancer
- adjuvant effects
- researcher mobility
- smart specialization strategy
- delivery
- Promotion of excellence
- small molecules
- increasing vaccine potential
- training
Field of Science
- 3.3 Health sciences
Smart Specialization Area
- Biomedicine, medical technologies and biotechnology
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.